Skopos Labs, Inc. Biomarin Pharmaceutical Inc Transaction History
Skopos Labs, Inc.
- $453 Million
- Q1 2025
A detailed history of Skopos Labs, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Skopos Labs, Inc. holds 564 shares of BMRN stock, worth $32,176. This represents 0.01% of its overall portfolio holdings.
Number of Shares
564
Previous 24
2250.0%
Holding current value
$32,176
Previous $1,000
3800.0%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BMRN
# of Institutions
669Shares Held
184MCall Options Held
1.24MPut Options Held
957K-
Black Rock Inc. New York, NY22.7MShares$1.3 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.08 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA17.8MShares$1.01 Billion1.06% of portfolio
-
Dodge & Cox San Francisco, CA15MShares$853 Million0.65% of portfolio
-
Viking Global Investors LP10.8MShares$616 Million2.55% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.6B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...